Can Alterity (ASX:ATH) Advance ATH434 Toward Approval?

📅 29/09/2026 05:30 📰 kalkinemedia 👁️ 2 lectures 🌍 Australie 📂 Science

Alterity Therapeutics (ASX:ATH) is a biotech developing ATH434 for Parkinson's-related disorders. Key drivers, risks and what to watch.